Home
>
National Drug Code (NDC)
>
AcetaZOLAMIDE
AcetaZOLAMIDE - 42291-103-90 - (Acetazolamide)
Drug Information of AcetaZOLAMIDE
| Product NDC: | 42291-103 |
| Proprietary Name: | AcetaZOLAMIDE |
| Non Proprietary Name: | Acetazolamide |
| Active Ingredient(s): | 250 mg/1 & nbsp; Acetazolamide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of AcetaZOLAMIDE
| Product NDC: | 42291-103 |
| Labeler Name: | AvKARE, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA084840 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120702 |
Package Information of AcetaZOLAMIDE
| Package NDC: | 42291-103-90 |
| Package Description: | 90 TABLET in 1 BOTTLE (42291-103-90) |
NDC Information of AcetaZOLAMIDE
| NDC Code | 42291-103-90 |
| Proprietary Name | AcetaZOLAMIDE |
| Package Description | 90 TABLET in 1 BOTTLE (42291-103-90) |
| Product NDC | 42291-103 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Acetazolamide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20120702 |
| Marketing Category Name | ANDA |
| Labeler Name | AvKARE, Inc. |
| Substance Name | ACETAZOLAMIDE |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Sulfonamides [Chemical/Ingredient] |
